ArticleJournal of cellular and molecular medicine2021

CDKN1C as a prognostic biomarker correlated with immune infiltrates and therapeutic responses in breast cancer patients.

Jianguo Lai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.